Research Study: Lp(A)
Condition:
cardiovascular disease and Lipoprotein(a)
Study Sponsor: Novartis
Study Investigator: Thomas Knickelbine, MD
Study Contact: Stephanie Ebnet
stephanie.ebnet@allina.com
612-863-6286
Every research study comes with its own unique risks and benefits; the study team will assess whether you’re an eligible candidate and ensure you’re provided with all the information you need to decide if participating is right for you.
About this Study:

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).
Eligibility Criteria:

  • Signed informed consent
  • Established CVD defined as one of the following:
    • History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
    • History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit
    • Symptomatic PAD (intermitted claudication with ankle-brachial index ≤0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia

Interested in participating in this study?

Reach out to the study contact directly, or fill out this form and we will contact you and assess whether you are an eligible candidate!